| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |